Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Sep 14, 2016 $8.84 $8.84 $8.84 $8.84 626 600
Sep 13, 2016 $9.00 $9.00 $9.00 $9.00 2 179 700
Sep 12, 2016 $13.19 $13.19 $13.19 $13.19 157 300
Sep 09, 2016 $12.37 $12.37 $12.37 $12.37 63 100
Sep 08, 2016 $13.04 $13.04 $13.04 $13.04 89 800
Sep 07, 2016 $13.01 $13.01 $13.01 $13.01 101 300
Sep 06, 2016 $12.85 $12.85 $12.85 $12.85 46 700
Sep 02, 2016 $12.53 $12.53 $12.53 $12.53 70 800
Sep 01, 2016 $12.66 $12.66 $12.66 $12.66 37 200
Aug 31, 2016 $12.78 $12.78 $12.78 $12.78 120 000
Aug 30, 2016 $13.31 $13.31 $13.31 $13.31 52 900
Aug 29, 2016 $13.27 $13.27 $13.27 $13.27 118 800
Aug 26, 2016 $13.22 $13.22 $13.22 $13.22 53 500
Aug 25, 2016 $13.30 $13.30 $13.30 $13.30 67 700
Aug 24, 2016 $13.58 $13.58 $13.58 $13.58 75 300
Aug 23, 2016 $14.63 $14.63 $14.63 $14.63 29 500
Aug 22, 2016 $14.82 $14.82 $14.82 $14.82 61 400
Aug 19, 2016 $14.56 $14.56 $14.56 $14.56 37 800
Aug 18, 2016 $14.83 $14.83 $14.83 $14.83 57 200
Aug 17, 2016 $15.13 $15.13 $15.13 $15.13 35 300
Aug 16, 2016 $15.23 $15.23 $15.23 $15.23 44 000
Aug 15, 2016 $15.22 $15.22 $15.22 $15.22 76 300
Aug 12, 2016 $15.40 $15.40 $15.40 $15.40 66 100
Aug 11, 2016 $15.23 $15.23 $15.23 $15.23 55 800
Aug 10, 2016 $15.10 $15.10 $15.10 $15.10 94 200
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT